TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmalex Norway AS
Closing information (x1000 EUR)
| Closing information | 2025/09 | 2024/09 | 2023/09 |
| Turnover |
1,759
|
2,204
|
1,857 |
| Financial expenses |
47
|
48
|
49 |
| Earnings before taxes |
-343
|
125
|
12 |
| Total assets |
845
|
761
|
622 |
| Current assets |
832
|
759
|
616 |
| Current liabilities |
442
|
447
|
306 |
| Equity capital |
-28
|
315
|
316 |
| - share capital |
9
|
9
|
9 |
Financial ratios
| Fiscal year | 2025/09 | 2024/09 | 2023/09 |
| Solvency |
-3.3%
|
41.4%
|
50.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-19.5%
|
5.7%
|
0.6% |
| Return on assets (ROA) |
-35.0%
|
22.7%
|
9.8% |
| Current ratio |
188.2%
|
169.8%
|
201.3% |
| Return on equity (ROE) |
1225.0%
|
39.7%
|
3.8% |
| Change turnover |
-453
|
426
|
-688 |
| Change turnover % |
-20%
|
24%
|
-27% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2025/09 | 2024/09 | 2023/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.